| Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer M Peifer, L Fernández-Cuesta, ML Sos, J George, D Seidel, LH Kasper, ... Nature genetics 44 (10), 1104-1110, 2012 | 1550 | 2012 |
| The 2021 WHO classification of lung tumors: impact of advances since 2015 AG Nicholson, MS Tsao, MB Beasley, AC Borczuk, E Brambilla, ... Journal of Thoracic Oncology 17 (3), 362-387, 2022 | 1079 | 2022 |
| Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT) F Barlesi, J Mazieres, JP Merlio, D Debieuvre, J Mosser, H Lena, ... The Lancet 387 (10026), 1415-1426, 2016 | 1017 | 2016 |
| PD-L1 immunohistochemistry comparability study in real-life clinical samples: results of blueprint phase 2 project MS Tsao, KM Kerr, M Kockx, MB Beasley, AC Borczuk, J Botling, ... Journal of Thoracic Oncology 13 (9), 1302-1311, 2018 | 756 | 2018 |
| Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers S Rousseaux, A Debernardi, B Jacquiau, AL Vitte, A Vesin, ... Science translational medicine 5 (186), 186ra66-186ra66, 2013 | 516 | 2013 |
| TUNEL apoptotic cell detection in tissue sections: critical evaluation and improvement F Labat-Moleur, C Guillermet, P Lorimier, C Robert, S Lantuejoul, ... Journal of Histochemistry & Cytochemistry 46 (3), 327-334, 1998 | 462 | 1998 |
| Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase … A Scherpereel, J Mazieres, L Greillier, S Lantuejoul, P Dô, O Bylicki, ... The Lancet Oncology 20 (2), 239-253, 2019 | 446 | 2019 |
| Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ AMC Dingemans, M Früh, A Ardizzoni, B Besse, C Faivre-Finn, ... Annals of Oncology 32 (7), 839-853, 2021 | 423 | 2021 |
| A grading system for invasive pulmonary adenocarcinoma: a proposal from the International Association for the Study of Lung Cancer Pathology Committee AL Moreira, PSS Ocampo, Y Xia, H Zhong, PA Russell, Y Minami, ... Journal of Thoracic Oncology 15 (10), 1599-1610, 2020 | 411 | 2020 |
| Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker V Hofman, C Bonnetaud, MI Ilie, P Vielh, JM Vignaud, JF Fléjou, ... Clinical cancer research 17 (4), 827-835, 2011 | 381 | 2011 |
| Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors E Brambilla, A Negoescu, S Gazzeri, S Lantuejoul, D Moro, C Brambilla, ... The American journal of pathology 149 (6), 1941, 1996 | 364 | 1996 |
| Best practices recommendations for diagnostic immunohistochemistry in lung cancer Y Yatabe, S Dacic, AC Borczuk, A Warth, PA Russell, S Lantuejoul, ... Journal of thoracic oncology 14 (3), 377-407, 2019 | 359 | 2019 |
| Prognostic effect of tumor lymphocytic infiltration in resectable non–small-cell lung cancer E Brambilla, G Le Teuff, S Marguet, S Lantuejoul, A Dunant, S Graziano, ... Journal of clinical oncology 34 (11), 1223-1230, 2016 | 357 | 2016 |
| SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas F Le Loarer, S Watson, G Pierron, VT de Montpreville, S Ballet, N Firmin, ... Nature genetics 47 (10), 1200-1205, 2015 | 342 | 2015 |
| Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors J George, V Walter, M Peifer, LB Alexandrov, D Seidel, F Leenders, ... Nature communications 9 (1), 1048, 2018 | 320 | 2018 |
| CD74–NRG1 Fusions in Lung Adenocarcinoma L Fernandez-Cuesta, D Plenker, H Osada, R Sun, R Menon, F Leenders, ... Cancer discovery 4 (4), 415-422, 2014 | 303 | 2014 |
| Subtype classification of lung adenocarcinoma predicts benefit from adjuvant chemotherapy in patients undergoing complete resection MS Tsao, S Marguet, G Le Teuff, S Lantuejoul, FA Shepherd, L Seymour, ... Journal of clinical oncology 33 (30), 3439-3446, 2015 | 298 | 2015 |
| PD-L1 testing for lung cancer in 2019: perspective from the IASLC pathology committee S Lantuejoul, M Sound-Tsao, WA Cooper, N Girard, FR Hirsch, AC Roden, ... Journal of Thoracic Oncology 15 (4), 499-519, 2020 | 294 | 2020 |
| Definition of synchronous oligometastatic non–small cell lung cancer—a consensus report AMC Dingemans, LEL Hendriks, T Berghmans, A Levy, B Hasan, ... Journal of Thoracic Oncology 14 (12), 2109-2119, 2019 | 275 | 2019 |
| The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group E Thunnissen, KM Kerr, FJF Herth, S Lantuejoul, M Papotti, RC Rintoul, ... Lung cancer 76 (1), 1-18, 2012 | 272 | 2012 |
